3GERLI S, SPAN0 F, di RENZO G C. Endometrial carcinoma in women 40 year old or younger : a case report and literature review [ J ]. Eur Rev Med Pharmacol Sci, 2014, 18 ( 14 ) : 1973-1978.
4ZHAO S,LI G,YANG L,et al. Response-specific progestin resist- ance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogest- erone acetate[J]. Oncol Lett,2013,5( 1 ) :139-144.
5JAFARI- SHOBEIRI M, MOSTAFA- GHARABAGHI P, ES- MAEILI H,et al. Fertility sparing treatment in young patients with early endometrial adenocarcinoma: case series [ J ]. Pak J Med Sci ,2013,29(2) :651-655.
6RICCIARDI E, MANIGLIO P, FREGA A, et al. Fertility- spar- ing treatment of endometrial cancer precursors among young women : a reproductive point of view [ J ]. Eur Rev Med Phar- macol Sci ,2012,16 (14) : 1934-1937.
7CHIVA L, LAPUENTE F, GONZ~LEZ- CORTIJO L, et al. Sparing fertility in young patients with endometrial cancer[ J]. Gynecol Oncol,2008,111 (2 Suppl) : S101-104.
8LAURELLI G, di VAGNO G, SCAFFA C, et al. Conservative treatment of early endometrial cancer: preliminary results of a pilot study[J]. Gynecol Oncol,2011,120( 1 ) :43-46.
9KUDESIA R, SINGER T, CAPUTO T A, et al. Reproductive and oneologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma [ J ]. Am J Obstet Gyneco1,2014,210 : e1 -4.
10GUNDERSON C C, FADER A N, CARSON K A, et al. Onco- logic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarci- noma: a systematic review [ J ]. Gynecol Oncol, 2012, 125 (2) :477-482.
二级参考文献48
1Denny L,Quinn M, Hacker N. FIGO Cancer Report 2012 [ J]. Int J Gynaecol Obstet, 2012,119 ( Suppl 2 ) : $89.
2Greer BE, Koh WJ, Abu-Rustum N, et al. Uterine Neoplasms. Clinical Practice Guidelines in Oncology[ J]. J Natl Compr Canc Netw, 2009,7 ( 5 ) :498-531.
3Zivanovic O, Carter J, Kauff ND, et al. A review of the challen- ges faced in the conservative treatment of young women with en- dometrial carcinoma and risk of ovarian cancer[ J]. Gynecol On- col, 2009,115(3) :504-509.
5Mao Y, Wan X, Chen , et al. Outcomes of conservative thera- py for young women with early endometrial adenocarcinoma [ J ]. Fertil Steril, 2010,93 ( 1 ) :283-285.
6Kim MK, Yoon BS, Park H, et al. Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine sys- tem for early-stae endometrial cancer in youn women: pilotstudy[J]. Int J Gynecol Cancer, 2011,21 (4) :673-677.
7Yamazawa K, Hirai M, Fujito A, et al. Fertility-preserving treat- ment with progestin, and pathological criteria to predict respon- ses, in young women with endometrial cancer[ J]. Hum Reprod, 2007,22 (7) : 1953-1958.
8Frumovitz M, Gershenson DM. Fertility-sparing therapy for young women with endometrial cancer [ J ]. Expert Rev Anticancer T- her, 2006,6( 1 ) :27-32.
9Benshushan A. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment [ J ]. Eur J Obstet Gynecol Reprod Biol, 2004,117(2) :132-137.
10Yang YC, Wu CC, Chen CP, et al. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer [ J]. Gynecol Oncol, 2005,99(2) :287-295.
